VRSK vs. DXCM
Compare and contrast key facts about Verisk Analytics, Inc. (VRSK) and DexCom, Inc. (DXCM).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: VRSK or DXCM.
Key characteristics
| VRSK | DXCM | |
|---|---|---|
| YTD Return | 21.09% | -40.09% |
| 1Y Return | 21.44% | -24.41% |
| 3Y Return (Ann) | 10.75% | -22.89% |
| 5Y Return (Ann) | 16.14% | 7.98% |
| 10Y Return (Ann) | 16.91% | 18.93% |
| Sharpe Ratio | 1.12 | -0.38 |
| Sortino Ratio | 1.57 | -0.11 |
| Omega Ratio | 1.24 | 0.98 |
| Calmar Ratio | 1.68 | -0.35 |
| Martin Ratio | 4.25 | -0.73 |
| Ulcer Index | 5.11% | 28.89% |
| Daily Std Dev | 19.34% | 54.67% |
| Max Drawdown | -30.88% | -94.61% |
| Current Drawdown | 0.00% | -54.34% |
Fundamentals
| VRSK | DXCM | |
|---|---|---|
| Market Cap | $40.66B | $29.04B |
| EPS | $6.47 | $1.65 |
| PE Ratio | 44.50 | 45.05 |
| PEG Ratio | 1.86 | 1.10 |
| Total Revenue (TTM) | $2.82B | $3.95B |
| Gross Profit (TTM) | $1.77B | $2.44B |
| EBITDA (TTM) | $1.51B | $940.70M |
Correlation
The correlation between VRSK and DXCM is 0.34, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
VRSK vs. DXCM - Performance Comparison
In the year-to-date period, VRSK achieves a 21.09% return, which is significantly higher than DXCM's -40.09% return. Over the past 10 years, VRSK has underperformed DXCM with an annualized return of 16.91%, while DXCM has yielded a comparatively higher 18.93% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
VRSK vs. DXCM - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Verisk Analytics, Inc. (VRSK) and DexCom, Inc. (DXCM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
VRSK vs. DXCM - Dividend Comparison
VRSK's dividend yield for the trailing twelve months is around 0.52%, while DXCM has not paid dividends to shareholders.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
VRSK Verisk Analytics, Inc. | 0.52% | 0.57% | 0.70% | 0.51% | 0.52% | 0.67% |
DXCM DexCom, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
VRSK vs. DXCM - Drawdown Comparison
The maximum VRSK drawdown since its inception was -30.88%, smaller than the maximum DXCM drawdown of -94.61%. Use the drawdown chart below to compare losses from any high point for VRSK and DXCM. For additional features, visit the drawdowns tool.
Volatility
VRSK vs. DXCM - Volatility Comparison
The current volatility for Verisk Analytics, Inc. (VRSK) is 5.20%, while DexCom, Inc. (DXCM) has a volatility of 10.15%. This indicates that VRSK experiences smaller price fluctuations and is considered to be less risky than DXCM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
VRSK vs. DXCM - Financials Comparison
This section allows you to compare key financial metrics between Verisk Analytics, Inc. and DexCom, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities